longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Medicinova

MNOV

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Medicinova(MNOV) the Revenue is 458.44 K (+240.6%), Beat estimate;the EBIT is -2.541 M (+29.55%), Beat estimate;the EPS is -0.05 (+28.57%), Beat estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B240.59%
0.00B44.28%
+0.00B284.87%
EBITExceed expectations
-0.00B29.55%
-0.00B6.43%
+0.00B23.12%
EPSExceed expectations
-0.0528.57%
-0.06339.53%
+0.013319.04%

Revenue

ActualEstimateUnit: USD
qf

EBIT

ActualEstimateUnit: USD
qf

Net income

ActualEstimateUnit: USD
qf

EPS

ActualEstimateUnit: USD
qf